• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Target ALS

A New York based ALS research organization that's leading the fight for a cure.

  • DONATE
  • About Us
    • Our Mission
    • Our Model
    • Our Impact
    • Our Founder
    • Our Team
    • Our Partners
  • For Scientists
    • Research Cores
      • Target ALS Data Engine
      • Longitudinal Biofluids Core
      • Human Postmortem Tissue Core
      • Stem Cell Core
      • Reagents Core
      • Animal Models Core
    • Funding Opportunities
    • Funded Projects
    • Annual Meeting
    • Science on Target Blog
  • Understanding ALS
    • The Science, Explained
      • Glossary
      • FAQ
      • ALS 101
    • Voices of ALS
    • Video Library
  • Take Action
    • ALS Awareness Month:
      Behind the Breakthrough
    • Support Geoff Greulich
    • The ALS Global Research Initiative (AGRI)
      • Global Natural History Study
      • Community Based Pop-Up Clinics
    • Ways to Give
    • Email Sign Up
    • Contact Us
    • Donate Now
  • News
    • Announcements
    • In the News
    • Newsletters & Reports

Biomarker

n-Lorem Foundation and Columbia University Establish Silence ALS Initiative

steckinsights · May 3, 2022 ·

N-Lorem Foundation

Alzheimer’s Drug Discovery Foundation (ADDF) and Target ALS Announce Partnership to Accelerate Biomarker Discovery and Development

steckinsights · Dec 21, 2021 ·

Under the Microscope: Gene Yeo on RNA-Directed Therapy for ALS Caused by a C9ORF72 Mutation

steckinsights · Oct 11, 2021 ·

Tiny Protein, Enormous Potential: Why TDP-43 Matters

steckinsights · Aug 30, 2021 ·

neurons

Under the Microscope: Christine Vande Velde on Seeking Solutions for Cellular Self Defense

steckinsights · Jul 8, 2021 ·

neurons

Target ALS Announces Second Round of 2020 Grant Recipients Focused on Discovering and Developing ALS Biomarkers

steckinsights · Dec 14, 2020 ·

Target ALS initiative

ALS/FTD Response Signals Resounding Desire for Collaboration

steckinsights · Dec 19, 2019 ·

Target ALS - AFTD

Case Study: Biomarkers Offer Optimism for People with ALS

steckinsights · Apr 19, 2018 ·

test tubes

New Biomarker Study with Academic, Industry and Philanthropic Partners

steckinsights · Apr 19, 2018 ·

Mikael Kristenson

Footer

Target ALS
  • Donate
  • Contact
  • Financial Reports
  • Call For Proposals
  • Annual Meeting
  • Privacy Policy
  • Credits

Follow Us

guidestar

We are a 501(c)(3) public charity (EIN: 81-0756743), eligible to receive tax-deductible contributions that directly support our mission to break down barriers to ALS research to find effective treatments.

The Target ALS (TALS) website is intended for informational purposes only. Opinions expressed may not be that of TALS or its employees. For more information about our digital policies, click here.

© 2023 Target ALS Foundation, Inc.
Target ALS Foundation
244 Madison Avenue #1025
New York, NY 10016
(332) 333-4140
Steck Insights WordPress Consulting